A study that was published on Tuesday has stated that the spread of malaria can be restricted in children, with the help of preventive anti-malarial medications. The conclusion was reached after trials were carried out on an excess of 3,000-children from Mali and Burkina Faso.
It was found by experts involved in the study that infection rates of malaria can be brought down by 70 to 85%, if preventive drugs are properly administered among children.
In the research, two different trials were conducted on the children. They received two different types of drugs namely sulphadoxine pyrimethamine and amodiaquine for an intermittent period.
It was reported that following the provision of such drugs, the children were protected against infections related to all kinds of malaria.
The treatment was found to be beneficial, specifically for people sleeping under mosquito nets. The researchers have stated that the best way to deliver this type of a treatment was by voluntary participation of the community.
The study has appeared in the publication known as Public Library of Science.
The research was completed only because of the combined efforts made by Diadier Diallo, the London School of Hygiene and Tropical Medicine; Alassane Dicko, Malaria Research and Training Centre, Mali and Amadou Konate from the Centre National de Recherche et de Formation sur le Paludisme in Ouagadougou.
Related News
- Funds insufficient for fighting malaria
- Mandy Moore to Assist Efforts to Curb Malaria Infection
- Malaria Vaccine to Be Out Soon
- New single dose malaria drug
- Malaria Vaccine Could Be Rolled Out by 2015
- Artesunate: A New Drug for Severe Malaria Patients
- Southeast Asian Countries Selling Poor Quality Anti-Malarial Drugs
